Angiodynamics Inc ANGO

$12.36 +0.34 (2.87%)

Valuation

Market cap
519,998,000
Revenue TTM
$320,170,000
Net income TTM
$-36,740,000
PE ratio
0.00
Forward PE
—
Profit margin
-11.48%
Debt to equity
0.00

Trading

Volume
631,300
Avg volume
667,224
Day's range
$11.76 – $12.47
Shares out
42,054,000
Stochastic %K
94%
Beta
0.30
Analysts
Strong Sell
Price target
$18.80

Price

Company profile

AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally. The company operates through Med Tech and Med Device segments. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. T...

Show more

AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally. The company operates through Med Tech and Med Device segments. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company's thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit for use in extracorporeal circulatory support procedures for periods of up to six hours, as well as with other manufacturers' off-the-shelf pump, filter, and reinfusion cannula facilitate venous drainage. It also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which include angiographic catheters, guidewires, drainage catheters, and micropuncture kits for use in invasive procedures. In addition, the company provides total abscession drainage catheters for multi-purpose/general and biliary configurations, and nephrostomy options; mini stick MAX Coaxial microintroducer kits and micro-introducer kits; ports; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero Microwave Tissue Ablation System includes solero microwave generator and the solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.

Industry
Medical Instruments & Supplies
Sector
Healthcare
Phone
518 795 1400
Website
https://www.angiodynamics.com
Address
14 Plaza Drive, Latham, United States

Latest news

Stocktwits

filecrux Oct 14, 11:27 AM
$ANGO AngioDynamics (vascular, cancer devices): Humana Medicare Advantage uses LCD L40205 for NanoKnife from Oct 1 in MACs lacking their own — only favorable intermediate-risk Grade Group 2 prostate cancer and colorectal liver metastases unfit for surgery or thermal ablation. NanoKnife sold $8.3M in the quarter to Aug 31, up 29%, about 10% of $80.9M sales; market value ~$480M at the Oct 12 close, FY27 sales guidance $336M-$341M. Catch: prior authorization still applies, and it is one insurer. New CEO Eric Honroth starts Nov 2.
0 replies
prismmarketview Oct 13, 5:24 PM
Blood clots can cause life-threatening complications, from pulmonary embolism to stroke. On World Thrombosis Day, we're looking at the medical technologies advancing how these conditions are prevented and treated. Three companies working in this space: AngioDynamics $ANGO Developing minimally invasive thrombectomy systems designed to remove blood clots. Penumbra $PEN Advancing computer-assisted clot-removal technology for pulmonary embolism and ischemic stroke. AtriCure $ATRC Developing left atrial appendage management technology to reduce the risk of clot-related stroke. Different approaches to a major global health challenge. #WorldThrombosisDay
0 replies
saaria Oct 12, 4:39 PM
$ANGO when 2$
1 replies
Estimize Oct 12, 1:58 PM
Wall St is expecting -0.07 EPS for $ANGO Q2 [Reporting 01/07 BMO] http://www.estimize.com/intro/ango?chart=historical&metric_name=eps&utm_c
0 replies
BioTechHealthX Oct 10, 5:54 AM
$ANGO AngioDynamics, Inc. (NASDAQ: ANGO) reported 13.2% Med Tech growth. Discover why higher-margin products and improving cash flow are central to its bullish case. https://biotechhealthx.com/biotech-news/angiodynamics-ango-grows-faster-but-can-the-cash-catch-up/
0 replies
saaria Oct 9, 8:46 PM 0 replies
teevee Oct 9, 4:41 PM 0 replies
teevee Oct 9, 4:40 PM 0 replies